ImaRx Therapeutics: Clinical Trials

2 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Terminated 2
Phase 2	2	Terminated 2

Follow ImaRx Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Transcranial Ultrasound in Clinical SONothrombolysis MRX-801, Placebo - Acute Ischemic Stroke	Phase 1 / Phase 2	Terminated	ImaRx Therapeutics	72	2006-12-01	2008-04-15
Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke perflutren lipid microsphere - Acute Ischemic Stroke	Phase 1 / Phase 2	Terminated	ImaRx Therapeutics		2005-03-01	2007-07-27

Conditions studied

Ischemic Stroke (2)

Interventions

perflutren (1)

Countries

France (1)  ·  United States (1)

Top investigators

Andrei Alexandrov, MD (1)  ·  Carlos Molina Cateriano, MD (1)